Document is current
Any future updates will be listed below
-
Authors
De Guio, Gabrielle
Wolf, Claire
Petit-Jean, Emilie
Guendouz, Ahmed
Vogel, Thomas
Bachellier, Philippe
Noll, Mélanie
Couturier, Franck
Michel, Bruno https://orcid.org/0000-0001-5961-1584
Gourieux, Bénédicte
-
Funding
Funding for this research was provided by:
This research received a specific grant from the "Direction Générale de l’Offre de Soins (DGOS)" of the French Ministry of Health as part of a clinical pharmacy project call.
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 5 March 2026
First Online: 24 March 2026
Declarations
:
: The study protocol and all its amendments were approved by the French Committee for the Protection of Persons of the Southwest Territories. Written informed consent was obtained from all individual participants. The French National Agency for Medicines and Health Products Safety (ANSM) was informed of the ethical approval. Research registration numbers: IDRCB A00391-56 and clinical trial number: NCT04020692.
: Thomas Vogel has received a speaker honorarium from Pfizer and Amgen companies The other authors have no relevant financial or non-financial interests to disclose.The other authors have no relevant financial or non-financial interests to disclose.
